Aptargroup (ATR) Total Non-Current Liabilities (2009 - 2026)
Aptargroup (ATR) posted quarterly Total Non-Current Liabilities of $5.1 billion for Q2 2026, up 6.12% year-over-year from $4.8 billion in Q2 2025, and up 1.01% on a QoQ basis from $5.0 billion in Q1 2026.
Aptargroup (ATR) Total Non-Current Liabilities (2009 - 2026) Analysis & Trends
Aptargroup has reported Total Non-Current Liabilities for 18 years, with the latest figure at $5.1 billion in Q2 2026.
- Total Non-Current Liabilities for Q2 2026 came in at $5.1 billion, up 6.12% year-over-year; the trailing twelve-month figure through Jun 2026 was $5.1 billion (up 6.12% YoY), and the FY2025 annual result was $5.2 billion, up 17.97% from the prior year.
- Total Non-Current Liabilities advanced to $5.1 billion in Q2 2026, from $5.0 billion in the prior quarter.
- Over five years, Total Non-Current Liabilities peaked at $5.2 billion in Q4 2025 and troughed at $4.0 billion in Q3 2022.
- A 5-year average of $4.5 billion and a median of $4.4 billion in 2023 frame the typical range for Total Non-Current Liabilities.
- The widest annual swing landed in 2023, when Total Non-Current Liabilities declined 2.09%; it then rose 17.97% in 2025.
- A 5-year view of Total Non-Current Liabilities shows it stood at $4.2 billion in 2022, then advanced by 5.55% to $4.4 billion in 2023, then fell by 0.28% to $4.4 billion in 2024, then gained by 17.97% to $5.2 billion in 2025, then slipped by 1.87% to $5.1 billion in 2026.
- Per Business Quant data, the three most recent Total Non-Current Liabilities figures were $5.1 billion in Q2 2026, $5.0 billion in Q1 2026, and $5.2 billion in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 1.92 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 48.34 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 6.34 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 985.45 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 17.56 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 996.30 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 8.96 Bn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 3.98 Bn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 12.41 Bn |
| 10 | Aptargroup | 8.58 Bn | 8.38 Bn | 365.52 Mn | 5.06 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5.06 Bn |
| Mar 31, 2026 | 5.07 Bn |
| Dec 31, 2025 | 5.15 Bn |
| Sep 30, 2025 | 5.00 Bn |
| Jun 30, 2025 | 4.83 Bn |
| Mar 31, 2025 | 4.45 Bn |
| Dec 31, 2024 | 4.37 Bn |
| Sep 30, 2024 | 4.60 Bn |
| Jun 30, 2024 | 4.44 Bn |
| Mar 31, 2024 | 4.42 Bn |
| Dec 31, 2023 | 4.43 Bn |
| Sep 30, 2023 | 4.29 Bn |
| Jun 30, 2023 | 4.33 Bn |
| Mar 31, 2023 | 4.24 Bn |
| Dec 31, 2022 | 4.15 Bn |
| Sep 30, 2022 | 3.98 Bn |
| Jun 30, 2022 | 4.26 Bn |
| Mar 31, 2022 | 4.41 Bn |
| Dec 31, 2021 | 4.14 Bn |
| Sep 30, 2021 | 4.06 Bn |